(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.



Fig. 3. Molecular characterisation of the dystroglycan morphant phenotype. (A,C,E,G) Embryos injected with a control MO. (B,D,F,H) Dystroglycan morphants. (A,B) Staining for slow twitch myosin. Dystrophin is clearly localised to myosepta of control-MO-injected embryos (C) and is undetectable in dystroglycan morphants (D). Dystroglycan morphants do not show a decrease of either dystroglycan (E,F) or dystrophin (G,H) mRNA expression.